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Abstract 
Background: Metabolic syndrome (MetS) increases the risk of morbidity and mortality from cardiovascular disease, 
and exercise training is an important factor in the treatment and prevention of the clinical components of MetS.
Objective: The aim was to compare the effects of high‑intensity interval training and steady‑state moderate‑inten‑
sity training on clinical components of MetS in healthy physically inactive adults.
Methods: Twenty adults were randomly allocated to receive either moderate‑intensity continuous training [MCT 
group; 60–80% heart rate reserve (HRR)] or high‑intensity interval training (HIT group; 4 × 4 min at 85–95% peak HRR 
interspersed with 4 min of active rest at 65% peak HRR). We used the revised International Diabetes Federation criteria 
for MetS. A MetS Z‑score was calculated for each individual and each component of the MetS.
Results: In intent‑to‑treat analyses, the changes in MetS Z‑score were 1.546 (1.575) in the MCT group and −1.249 
(1.629) in the HIT group (between‑groups difference, P =  0.001). The average number of cardiometabolic risk fac‑
tors changed in the MCT group (−0.133, P = 0.040) but not in the HIT group (0.018, P = 0.294), with no difference 
between groups (P = 0.277).
Conclusion: Among apparently healthy physically inactive adults, HIT and MCT offer similar cardiometabolic protec‑
tion against single MetS risk factors but differ in their effect on average risk factors per subject.
Trial registration ClinicalTrials.gov NCT02738385 registered on March 23, 2016
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Background
Disorders of the metabolic system have a key patho-
physiological role in the early stages of excess adiposity, 
elevated blood pressure, insulin resistance, abnormal glu-
cose metabolism and dyslipidemia [elevated triglyceride 
levels and low-density lipoprotein cholesterol (LDL-c), 
and reduced high-density lipoprotein cholesterol (HDL-
c)], producing coronary vasoconstriction, increasing car-
diac oxygen consumption and leading to fatal events [1, 
2]. This cluster of findings is recognized as metabolic syn-
drome (MetS) [3] and strongly predicts the risk of devel-
oping type 2 diabetes, hypertension and cardiovascular 
disease (CVD), which remains the leading cause of death 
worldwide [4–8].
Recently, Barceló [9] estimated that the number of 
CVD deaths in Latin America will increase by more 
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than 60% between 2000 and 2020, while CVD deaths will 
increase by only 5% in high-income countries during the 
same period. The findings of the INTERHEART case–
control study in Latin America showed that abdominal 
obesity, dyslipidemia, and hypertension were associated 
with high population-attributable risks of 48.5, 40.8, and 
32.9%, respectively [10]. In the same retrospective study, 
daily consumption of fruits or vegetables and regular PA 
reduced the risk of acute myocardial infarction. There-
fore, interventions aimed at the reduction of modifiable 
risk factors are thought to be the most effective way to 
prevent the onset of MetS and potentially CVD in Latin 
America.
On the other hand, MetS is determined by genetic 
predisposition as well as environmental factors that 
may promote its development, such as low levels of 
physical activity (PA), large volumes quantities of sed-
entary time (sitting), and poor eating habits [5, 8]. The 
adoption and maintenance of PA are critical foci in the 
metabolic health management and overall health of 
individuals with potential medical risks, including acute 
complications such as cardiac events, hypoglycemia, 
and hyperglycemia. Strong evidence shows that physical 
inactivity (<150  min  week−1 of moderate-intensity PA 
or 75  min  week−1 of vigorous-intensity PA) are jointly 
associated with increased cardiometabolic morbidity 
and mortality in a dose-dependent manner [11, 12]. Cur-
rently, physical inactivity is the fourth leading risk factor 
for global mortality and is comparable in that respect to 
smoking and obesity, accounting for 6% of all deaths [13]. 
Experimental studies indicate that physical inactivity and 
sedentary time result in alterations in cardiovascular [14] 
and metabolic biomarkers [15, 16].
Systematic reviews [17–19] have found that physi-
cally inactive adults who participate in supervised inter-
val training in clinical settings improve their exercise 
capacity, quality of life, maximal oxygen consumption 
 (VO2max) and metabolic control. A growing body of evi-
dence has demonstrated comparable or greater improve-
ments in cardiovascular function using low-volume 
high-intensity training (HIT) compared to traditional 
moderate-intensity continuous training (MCT) [17, 18, 
20, 21]. Furthermore, participation in HIT reduces risk 
factors that are associated with MetS, bringing improve-
ment in features such as the oxidative metabolism–
dependent energy system, metabolic capacity, qualitative 
profile of skeletal muscle fiber type, muscle mass, and 
fiber diameter [2, 22–24]. In primary prevention, Pattyn 
et al. [2] shown that endurance training has a favourable 
effect on most of the cardiovascular risk factors associ-
ated with the MetS such as: a mean reduction in abdomi-
nal obesity, blood pressure decrease and a mean increase 
in HDL-c. In this same line, in previously clinical trials 
[22, 25–28] has been investigated the effect of exercise 
in different populations and for single cardiovascular 
risk factors, but none have specifically focused on the 
insufficient PA and the concomitant effect of HIT on all 
associated cardiovascular risk factors. However, few ran-
domized trials have directly evaluated the effects of MCT 
or HIT on cardiometabolic health among inactive adults 
[2, 25–28].
Although the epidemiologic transition and epidemic 
of CVD have been well documented in Latin Americans 
[29–31], relatively little research on their PA [32–34] and 
physical fitness exists. Moreover, Latin American coun-
tries [6, 7] have a similar or even greater prevalence of 
MetS among adults than developed countries [8]. In this 
context, ethnicity and age has been associated with the 
development of MetS specially in Hispanic population [1, 
3, 6, 7]. According to the definition of the National Cho-
lesterol Education Program–Adult Treatment Panel III of 
the United States, the prevalence of MetS in adults was: 
32% in Hispanic Americans; 22% in African Americans; 
and 24% in European Americans [3]. In Colombia, Mar-
tínez-Torres et al. [32] reported the predisposing factors 
for having a MetS included: being male, over 25 years old 
and overweight or obese, all of them related to metabolic 
disorders as previously described in apparently healthy 
women [31]. In addition, the public policy recommenda-
tions also highlight the need for healthy adults to have 
an activity plan that integrates preventative and therapy 
recommendations [40–42]. For this reason, a randomized 
clinical trial (RCT) comparing different intensities of 
exercise training in adults with insufficient PA with a 
large age range and different ethnic groups are clinically 
relevant because it can provide evidence for a precise 
[21, 35–37], prescribed intensity of exercise training to 
achieve optimal outcomes in this population [40–42].
Therefore, the purpose of this RCT was to compare 
the effects of MCT and HIT on the risk factors for MetS 
among apparently healthy physically inactive adults. We 
hypothesized that HIT and MCT would induce simi-
lar reductions in the risk factors for MetS and similar 
increases in exercise capacity when training frequency 
and session duration were equal in both types of training.
Methods
Study design and setting
The High Interval Intensity Training and ideal cardiovas-
cular Heart Study (HIIT-Heart Study) was an RCT (Clini-
calTrials.gov ID: NCT02738385) that included physically 
inactive Colombian adults who were randomly allocated 
to either an MCT group or an HIT group. The study was 
performed in accordance with the Declaration of Hel-
sinki [38] and was approved by the local office of the 
Medical Research Ethics Committee at the University of 
Page 3 of 11Ramírez‑Vélez et al. J Transl Med  (2017) 15:118 
Santo Tomás (ID 27-0500-2015). Cardiometabolic health 
parameters and physical fitness outcomes were assessed 
at baseline and 12 weeks later. We provide an overview of 
the methods per the Consolidated Standards of Report-
ing Trials (CONSORT) checklist [39].
Participants and recruitment
This RCT was conducted at the University of Rosario 
and the University of Santo Tomás (Bogota, Colom-
bia) from February 2015 to May 2016. Participants aged 
18–45  years who were inactive and had a body mass 
index (BMI)  ≥18 and  ≤30  kg/m2 and who were will-
ing and almost immediately available to participate in 
the study were recruited from the Centre of Studies in 
Physical Activity Measurements (in Spanish, CEMA) via 
posted study recruitment flyers at community centers, 
study recruitment announcements at the CEMA, and 
word of mouth. Individuals with a history of a medical 
condition identified by the American Heart Association 
(AHA) as an absolute contraindication to exercise test-
ing were excluded from this study [40]. We have recently 
published a complete description of the HIIT-Heart 
Study design, methods, and primary outcomes for our 
current cohort [21]. Participants were required to sign a 
written informed consent form.
Blinding and randomization
Random allocation into the two study groups was per-
formed by the CEMA at the University of Rosario in 
Bogotá, Colombia using block randomization with 
a block size of four. As each consecutive participant 
entered this RCT, he/she was randomly allocated to 
either the MCT group or the HIT group according to a 
computer-generated group allocation sequence. The ran-
domization sequence was not concealed from the inves-
tigator who was responsible for assigning participants 
to groups. The principal investigators and statisticians 
were blinded to treatment allocation throughout the trial 
protocol.
Interventions
Both groups participated in the cardiometabolic program 
as recommended by both the American College of Sports 
Medicine (ACSM) [41] and the AHA [40, 42] guidelines 
for ideal cardiovascular health and disease reduction. 
At the beginning of the training protocol, we measured 
the participants’ weight to determine the weekly energy 
expenditure that was necessary to achieve their target of 
12 kcal kg−1 week−1 (iso-energetic).
The MCT and HIT interventions lasted 12  weeks, 
with three sessions per week consisting of fast walk-
ing or running on a treadmill with the deck inclined to 
reach the desired intensity. HR was recorded during 
each session using an HR monitor (Polar Pacer, USA). 
In addition, Borg ratings were measured during each 
exercise session. An initial 2-week preparatory phase 
of training was performed to bring participants up to a 
6 kcal kg−1 week−1 goal (~150 kcal per session or equiva-
lent to 6 Mets), which was progressively increased by 
2 kcal kg−1 week−1 until week 4 and was then maintained 
at 12 kcal kg−1 week−1 for weeks 5 through 12 (~300 kcal 
per session or equivalent to 10 Mets). The duration of 
each individual session depends on the number of visits 
required to reach the target kcal kg−1 week−1.
Moderate‑intensity continuous training (MCT) group
Exercise training sessions were designed to elicit a 
response in the acceptable moderate-to-vigorous range, 
i.e., 55–75% heart rate reserve, and were adjusted accord-
ing to ratings on the Borg scale. Each session consisted 
of a warm-up (5 min), followed by 15–55 min of tread-
mill walking/running (15–35 min during the 2-week pre-
paratory phase) and a final relaxation/cool-down period 
(10 min).
High‑intensity training (HIT) group
We calculated the training energy expenditure for par-
ticipants’ age ranges to meet the consensus public health 
recommendations included in the HIIT-RT Study [21]. 
A complete description of the design and methods has 
been published elsewhere [21]. During the 2-week pre-
paratory phase, subjects warmed up at 65% heart rate 
reserve (5 min), then performed 4  ×   4 min intervals at 
60–80% heart rate reserve interspersed with 4  min of 
active recovery at 55% heart rate reserve. During weeks 
3–12, subjects performed 4  ×  4 min intervals at 85–95% 
heart rate reserve (remaining in the target zone for at 
least 2  min) interspersed with 4  min of active recov-
ery at 65% heart rate reserve and a cool-down (5  min), 
with a range of total exercise time ranging from 35 to 
55 min (including warm-up and cool-down). We selected 
6–12  kcal  kg−1  week−1 per week because this dose of 
kcal/kg/week has produced changes in  VO2max that 
placed about 70% of the initially sedentary population 
above the cut point for low fitness, as defined in by both 
the ACSM) [41] and the AHA [40, 42] guidelines for car-
diovascular disease reduction.
Participants in both groups were supervised dur-
ing each exercise training session by an investigator or 
research assistant. Exercise training was conducted at the 
“CEMA” fitness center on the campus of the University of 
Rosario, which contained the treadmills needed to com-
plete the prescribed exercise programs. Each participant 
was instructed to inform the supervisor immediately 
if he or she experienced any unusual symptoms during 
exercise training and to consult a physician if needed. 
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Participants were instructed to refrain from exercise 
training and to avoid changing their physical activity lev-
els outside the study. All participants reported that they 
adhered to these instructions.
We estimated the energy expenditure during the exer-
cise sessions by calibrating the energy expenditure to the 
HR during the maximal oxygen uptake tests performed 
at the baseline and post-intervention time points. The 
regression in energy expenditure was calculated for 
each participant according to both the HR and the num-
ber of minutes spent exercising during the training ses-
sions. The trainers were physical therapists and physical 
educators with experience developing and monitoring 
exercise programs with clinical populations. Adherence 
to the exercise program was encouraged by the exer-
cise professional who supervised each of the group ses-
sions. To maximize adherence to the training program, 
the trainer supervised no more than 3–5 participants 
simultaneously. Although diet was not controlled, partic-
ipants met with the study dietician for nutrition assess-
ment and counselling at baseline, and an individualized 
iso-energetic nutrition intervention plan was developed 
from the baseline food intake assessment according to 
participant preferences. This plan was standardised at 
1300–1500  kcal  day−1 (50–55% carbohydrates, 30–35% 
total fat, <7% saturated fat and 15–22% protein), distrib-
uted across 3–4 meals per day.
Data collection and outcome measures
The outcome measures were assessed at baseline and 
12-week follow-up by personnel who were blinded to the 
treatment allocation. The data were recorded on stand-
ardized forms and entered into a secured Microsoft Excel 
Access database that included quality control checks 
(e.g., range checks, notifications of missing data).
Anthropometric and body composition variables were 
collected at the same time in the morning, between 7:00 
a.m. and 10:00 a.m. Body weight and height were meas-
ured following standard procedures with an electronic 
scale  (Tanita® BC544, Tokyo, Japan) and a mechanical 
stadiometer platform  (Seca® 274, Hamburg, Germany), 
respectively. BMI was calculated as body weight in kilo-
grams divided by the square of height in meters (kg/m2). 
Waist circumference (WC) was measured at the narrow-
est point between the lower costal border and the iliac 
crest using a tape measure  (Ohaus® 8004-MA, New Jer-
sey, USA). In cases in which this point was not evident, 
WC was measured at the midpoint between the last rib 
and the iliac crest [43]. We measured each variable twice 
and used the average unless the first and second measures 
varied ≥1%. In such cases, we used the median of three 
measurements. In all measures, we found very good test–
retest reliability [body weight (intra-class correlation, 
ICC  =  0.983), height (ICC  =  0.973), BMI (ICC 0.897), 
and WC (ICC  =  0.967)]. The percentages of body fat 
mass and lean mass were obtained using the Tetrapolar 
Bioelectrical Impedance Analysis (BIA) system (SECA 
mBCA  515®, HANS E. RÜTH S.A, Hamburgo Alema-
nia), with subjects standing barefoot on the metal con-
tacts. This method was previously validated by experts 
in the field [44]. Our lab’s analysis showed strong agree-
ment between the two methods as reflected in the range 
of BF%. This result shows that BIA and dual-energy X-ray 
absorptiometry are comparable methods for measuring 
body composition with higher or lower body fat percent-
ages (unpublished data). Before testing, the participants 
were required to adhere to the following instructions 
from the BIA manufacturer [44]: (1) not to eat or drink 
within 4 h of the test, (2) not to consume caffeine or alco-
hol within 12 h of the test, (3) not to take diuretics within 
7  days of the test, (4) not to perform physical exercise 
within 12 h of the test, and (5) to urinate within 30 min 
of the test. BIA measurements were performed at 50 kHz 
with a 0.8  mA sine wave constant current under stand-
ard conditions [44]. The measurement was made twice, 
and the average value was used. Inter-observer variabil-
ity was R =  0.89. BIA has been extensively used as the 
gold standard against other body composition methods 
in subjects from the same region of origin as the current 
participants [44].
Blood pressure was measured using an electronic oscil-
lometric device (Riester Ri-Champion model, Jungin-
gen, Germany) according to the recommendations of 
the Association for the Advancement of Medical Instru-
mentation [45]. Prior to blood pressure monitoring, 
the accuracy of the device was tested using a standard 
mercury sphygmomanometer in a random subsample 
(n = 25) to ensure that there was no consistent difference 
(>10 mmHg) in blood pressure. To calculate the mean 
arterial pressure, the diastolic blood pressure was added 
and the sum was added to the systolic blood pressure. 
Inter-observer variability was R = 0.96.
Blood samples were collected between 5:30 and 7:00 
a.m. by two experienced phlebotomists after  ≥12  h of 
fasting. Blood samples were obtained from an antecubital 
vein, and analyses were subsequently completed within 
one day of collection. The biochemical profile included 
plasma lipid triglycerides, total cholesterol, HDL-c, 
LDL-c, and glucose (measured by enzymatic colorimet-
ric methods). Inter-assay reproducibility (coefficient of 
variation) was determined via ten replicate analyses of 
five plasma pools over 15 days and was shown to be 2.6, 
2.0, 3.2, 3.6% for triglycerides, total cholesterol, HDL-c 
and LDL-c, respectively, and 1.5% for serum fasting glu-
cose. Additional outcomes in this study were participant 
adherence and adverse events. Total exercise time was 
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defined as the total time spent on exercise training dur-
ing the study. Data on participant adherence to the pre-
scribed exercise training variables are expressed in the 
intervention section.
We used the revised International Diabetes Fed-
eration (IDF) [46] criteria for MetS: (i) increased waist 
circumference (males  ≥94  cm and females  ≥80  cm); 
(ii) increased triglycerides (≥150  mg/dl); (iii) reduced 
HDL-c (males  <40  mg/dl and females  <50  mg/dl); 
(iv) increased blood pressure (≥130  mm Hg systolic 
or ≥85 mm Hg diastolic); and (v) increased fasting glu-
cose (≥100 mg/dl). To test the effects of exercise train-
ing on MetS, we used a continuous Z-score, rather than 
a series of dichotomous scores. This concept has been 
proposed by other researchers to represent and detect 
overall metabolic changes more accurately represent and 
detect overall metabolic changes for several reasons [22, 
46]. Firstly, the continuous score would be more sensi-
tive to small and large changes that do not change the 
IDF criteria [22]. Secondly, the continuous score would 
be less sensitive to small changes that occur in the vicin-
ity of the diagnostic criteria for any one variable [22]. 
Thus, composite continuum score of MetS risk has been 
observed in several adult studies and has been demon-
strated to be a good method to assess overall cardiomet-
abolic risk [34]. The MetS Z-score was calculated from 
individual subject data, IDF criteria [46], and standard 
deviations using data from the entire subject cohort at 
baseline. The equation used was MetS Z-score =  [(♂40 
or ♀50—HDL-c)/SD multiplied by (−1)]  +  [(triglyc-
erides—150)/SD]  +  [(fasting plasma glucose—100)/
SD]  +  [(WC—♂94 or ♀80)/SD]  +  [(mean blood 
pressure—100)/SD].
Statistical analysis
To retain the data of all randomly allocated participants, 
an intention-to-treat analysis (all randomly assigned 
patients) was performed. Prior to the planned statistical 
analyses, a preliminary analysis was conducted (Kolmog-
orov–Smirnov test) to confirm the normality of the data. 
Once it was confirmed that the sample data satisfied the 
normality assumption, statistical analyses relevant to our 
main research interest were conducted. t-tests for con-
tinuous variables and Chi square for categorical variables 
were used to investigate any possible differences in base-
line characteristics and adherence between the groups. 
We used a generalized linear model (GLM) to analyze 
the influence of the different doses of exercise training 
on MetS components and body composition outcomes 
with repeated measures [2 (group) × 2 (test time)]. Inter-
group differences in changes with time were tested using 
the impaired t test. Cohen’s d effect sizes (ES) were also 
calculated to determine the magnitude of the group 
differences. ES was classified as small, medium, and large 
as <0.20, 0.2–0.6 and 0.6–1.2, respectively [47]. The sig-
nificance of the interactions effects between variables was 
tested using Spearman correlation analyses and denoted 
as rs. All reported P values were two-sided (P < 0.05). Sta-
tistical analyses were conducted using PASW Statistics 
17 for Windows (SPSS, Inc., Chicago, Illinois).
Results
Figure  1 shows the CONSORT flowchart of the rand-
omized clinical trial. A total of 28 potential physically 
inactive subjects were assessed for eligibility. Seven of 
them were excluded because they did not meet the inclu-
sion criteria. Ten participants were randomly allocated to 
the MCT group, and 11 were allocated to the HIT group. 
After allocation, one participant in the MCT group with-
drew for reasons unrelated to this study (lack of time due 
to work schedule).
The baseline characteristics of the MCT group, HIT 
group and total sample are outlined in Table  1. The 
t-test or Chi square indicated that no statistically signifi-
cant differences in the baseline characteristics (P > 0.05) 
existed between the groups.
Table  2 list the effects of the exercise interventions 
on MetS components. For MetS Z-score a significant 
main effect of time was observed in MCT (P  =  0.009, 
ES = 0.82) and HIT (P = 0.015, ES = 0.55) groups. The 
difference between groups was −2.795 (95% CI 1.276–
4.311, P = 0.001) time × group (P = 0.001). In addition, 
we calculated the frequency of the MetS risk factors at 
each time point and the average number of MetS risk fac-
tors for each training group. The average number of car-
diometabolic risk factors changed by −0.133 in the MCT 
group (P = 0.040); ES = 0.67 and 0.018 in the HIT group 
(P = 0.294); ES = 0.13 (no significant difference between 
groups  =  −0.152; P  =  0.227). There was a significant 
increase in fasting glucose from week 0 to week 12 in the 
MCT group (P =  0.039); ES =  0.19 and the HIT group 
(P = 0.001); ES = 0.29. Although the t-test did not reveal 
significant differences between the groups [1.6 mg (95% 
CI −8.5–11.8; P = 0.078)], a meaningful ES increase was 
observed in favor of the MCT group, ES =  1.19. Mean 
blood pressure significantly decreased from week 0 to 
week 12 in the HIT group (P = 0.019 ES = 0.24), as did 
WC (P = 0.006 ES = 0.27) and TG (P = 0.012 ES = 0.39) 
in the MCT group.
rs for various anthropometric and body composition 
variables and the MetS Z-score after 12  weeks of train-
ing are presented in Table 3. Negative correlations were 
observed between the MetS Z-score, weight (rs = −0.627, 
P =  0.011), BMI (rs = −0.756, P  <  0.001) and body fat 
(rs = −0.858, P < 0.001) in the HIT group. There were no 
significant correlations in the MCT group.
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No adverse events were reported over the course of this 
investigation. There were differences in the total exer-
cise time between groups (MCT, 1100 ±  258 min; HIT, 
1031  ±  147  min, training days (MCT, 35.5  ±  1.3  days; 
HIT, 35.4 ± 0.9 days).
Discussion
To our knowledge, this is the first RCT to compare the 
effects of different modes of exercise training on the clin-
ical risk factor profile for MetS among apparently healthy 
physically inactive Latin American adults. The present 
study demonstrates that HIT was a more potent stimulus 
than MCT at improving a sensitive cluster of MetS risk 
factors, although it failed to significantly improve indi-
vidual factors compared with MCT. Additionally, HIT 
produced stronger and moderately significant changes in 
MetS Z-score in terms of weight, BMI, and body fat.
There are divergent findings regarding MetS risk fac-
tors and HIT compared with MCT programs [11, 18, 20, 
48–50]. Our study showed a higher MetS Z-score reduc-
tion after HIT than after MCT. The lowering of the MetS 
Z-score by supervised training is similar to what others 
have found in at risk patients [22, 51–53]. In addition, 
we found that HIT or MCT significantly reduced indi-
vidual risk factors as others have found previously [22, 
53]. These include reducing triglycerides levels, fat mass, 
abdominal obesity and mean blood pressure [2]. How-
ever, the MCT group had a higher baseline MetS Z-score 
than the HIT group, resulting in a greater improve-
ment (ES = 0.82). In contrast to the current results, the 
RUSH-Study, which was performed with 81 middle-aged 
healthy men, showed similar positive effects on the MetS 
Z-score when HIT and MCT were compared [51]. How-
ever, in the aforementioned research, the HIT interven-
tion included work intervals threefold longer than in the 
current study and thus a more prevalent aerobic com-
ponent in the former, closer to MCT-induced adaptive 
loads [18].
Assessed for eligibility (n= 28)
Excluded  (n= 7)
Not meeting inclusion criteria (n= 4)
Declined to participate (n= 1)
Other reasons (n= 2)
Analysed  (n=  9)
Excluded from analysis (give reasons) (n= 0)
Lost to follow-up (give reasons) (n= 1)
One participant withdrew due to work 
MCT Group
Allocated to intervention (n= 10)
Received allocated intervention (n= 10)
Lost to follow-up (give reasons) (n= 0)
HIT Group
Allocated to intervention (n= 11)
Received allocated intervention (n= 10)
Analysed  (n= 11)
Excluded from analysis (give reasons) (n= 0)
Allocation
Analysis
Follow-Up
Randomized (n= 21)
Enrollment
–
–
–
–
–
– –
–
Fig. 1 CONSORT guidelines flow diagram for enrolment and randomization HIIT‑heart study
Page 7 of 11Ramírez‑Vélez et al. J Transl Med  (2017) 15:118 
Regarding unhealthy populations, studies have shown 
divergent findings. Confirming our results, Tjønna et al. 
[52] observed fewer subjects with MetS and fewer MetS 
risk factors in adults diagnosed with MetS after 16 weeks 
of HIT compared with MCT. In contrast, Johnson et al. 
[53] did not confirm the superiority of HIT compared 
with MCT in overweight and obese populations. Simi-
larly, Earnest et  al. [54] observed similar improvements 
in the MetS Z-score and the number of MetS risk factors 
between overweight males who participated in HIT and 
MCT. Due to methodological differences across stud-
ies (i.e., sex; age; initial health, weight and fitness status; 
prescribed medication; type and intensity of exercise, or 
interval duration; length of the exercise program) and the 
impact of such differences on outcomes [55–57], it is dif-
ficult to draw general conclusions. These and other pos-
sible factors need to be studied. The mechanism through 
which HIT had a greater effect than MCT on metabolic 
biomarkers compared to MCT is not clear. In the cur-
rent study, participants in the HIT completed 4 × 4 min 
of exercise up to 95% of HRmax three days per week for 
12 weeks, while the MCT group trained at only 55–75% 
of HRmax. In this context, we speculate that both train-
ing intensities might induce additive improvement in 
the oxidative metabolism–dependent energy system, 
metabolic capacity, qualitative profile of skeletal mus-
cle fiber type, muscle mass and fiber diameter [55, 56, 
58], although with potentially greater impact after HIT 
than after MCT. Further research is needed to reach a 
consensus.
No differences (time  ×  group) were found in sin-
gle MetS risk factors changes between HIT and MCT, 
although a significant increase in fasting glucose from 
baseline to post-exercise training was observed in both 
groups. However, levels of fasting glucose were within 
the healthy range. Although there are limitations to com-
paring Cohen’s scores in our study, the Cohen’s d value 
suggests important clinical applicability. Overall, we were 
unable to detect consistent superiority of HIT versus 
MCT programs (or vice versa) on MetS in healthy adults 
[18].
Furthermore, the beneficial effects of exercise on 
MetS Z-score were achieved without concomitant lean 
mass gainer, however, a decrease in fat mass was associ-
ated with reductions in the MetS Z-score (rs = −0.858, 
P < 0.001) in the HIT group, which emphasizes meaning-
fulness of this change in body composition. Interestingly, 
the WC decreased significantly in both groups, however, 
t-test did not reveal significant differences between the 
groups. Changes in body composition, or more precisely, 
changes in abdominal obesity and fat mass seem to be 
an important factor when an exercise intervention for 
reducing CVD markers is planned. In the present study 
we showed that a significant reduction in MetS Z-score is 
possible also in the absence of change in lean mass.
The strengths of this study included the use of a novel 
Z-score to evaluate the effects of different exercise pro-
grams on the risk of MetS; this scoring method provides 
an increased level of sensitivity. Each subject completed 
at least 32 of 36 exercise sessions, and researchers super-
vised each session while the subjects’ HR was being 
monitored.
A primary limitation of this study was the lack of a 
true non-exercise control group. Thus, we were una-
ble to determine causality in our interpretation of the 
observed exercise-induced improvements in cardiomet-
abolic health parameters within the groups. Second, as 
a common tool to assess body weight and relevant body 
composition parameters, BIA was used in the present 
study. However, it is not the “gold standard” body com-
position measure. Due to this and other limitations (e.g., 
relatively small sample size; single site design), it will be 
important not to over-interpret the results of this RCT. 
Lastly, we cannot determine the directions of the associ-
ations nor causality observed in this study with absolute 
certainty. Future studies may consider tighter regulation 
of these factors to control their effects during a relatively 
longer intervention.
Table 1 Baseline participant characteristics
BMI body mass index
Total sample 
(n = 20)
MCT 
(n = 9)
HIT 
(n = 11)
Sex, N (%)
 Male 8 (40.0) 5 (55.6) 3 (27.3)
 Female 12 (60.0) 4 (44.4) 8 (72.7)
Age, mean (sd), years 31.8 (7.8) 31.4 (6.4) 32.1 (9.0)
Race/ethnicity, N (%)
 Black or Afro‑Colombian 18 (90.0) 7 (77.7) 11 (100)
 Others (indigenous) 2 (10.0) 2 (22.3) 0 (0.0)
Socioeconomic level, N (%)
 Low‑mid 11 (55.0) 5 (55.5) 6 (54.5)
 Mid‑high 9 (45.0) 4 (45.5) 5 (45.4)
Education, N (%)
 Secondary 1 (5.0) 0 (0.0) 1 (9.1)
 Technical 1 (5.0) 1 (11.1) 0 (0.0)
 University 18 (90.0) 8 (88.9) 10 (90.9)
Occupation, N (%)
 Student/work 15 (80.0) 7 (77.7) 9 (81.8)
 Housewife 5 (20.0) 2 (22.3) 3 (18.2)
Marital status
 Single 4 (20.0) 3 (33.3) 1 (10.0)
 Married/de facto 16 (80.0) 6 (66.3) 10 (90.0)
Height, mean (sd), m 1.67 (0.06) 1.69 (0.05) 1.68 (0.09)
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Conclusion
HIT and MCT offer similar metabolic and cardiovascu-
lar protection against single MetS risk factors but not the 
average risk factors per subject. These effects could be 
enhanced with a reduction in fat mass that was observed 
only when HIT was performed. Thus, the improvement 
in the cardiovascular profile achieved in the present 
study may be an effective strategy for reduction in MetS 
Z-score and improving the health trajectory of physically 
inactive adults.
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